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Dimerization of single span transmembrane receptors under-
lies their mechanism of activation. p75 neurotrophin receptor
plays an important role in the nervous system, but the under-
standing of p75 activation mechanism is still incomplete. The
transmembrane (TM) domain of p75 stabilizes the receptor
dimers through a disulfide bond, essential for the NGF signal-
ing. Here we solved by NMR the three-dimensional structure of
the p75-TM-WT and the functionally inactive p75-TM-C257A
dimers. Upon reconstitution in lipid micelles, p75-TM-WT
forms the disulfide-linked dimers spontaneously. Under reduc-
ing conditions, p75-TM-WT is in a monomer-dimer equilib-
rium with the Cys257 residue located on the dimer interface. In
contrast, p75-TM-C257A forms dimers through the AXXXG
motif on the opposite face of the -helix. Biochemical and cross-
linking experiments indicate that AXXXG motif is not on the
dimer interface of p75-TM-WT, suggesting that the conforma-
tion of p75-TM-C257A may be not functionally relevant. How-
ever, rather than mediating p75 homodimerization, mutagene-
sis of the AXXXG motif reveals its functional role in the
regulated intramembrane proteolysis of p75 catalyzed by the
-secretase complex. Our structural data provide an insight into
the key role of the Cys257 in stabilization of the weak transmem-
brane dimer in a conformation required for the NGF signaling.
The neurotrophins (NTs)6 are a family of neurotrophic fac-
tors that control multiple aspects of nervous system develop-
ment and function. NTs interact with two distinct receptors, a
cognate member of the Trk receptor tyrosine kinase family and
the p75 neurotrophin receptor, a member of the tumor necrosis
factor (TNF) receptor superfamily of death receptors (1). The
most prominent biological function of p75 may be the induc-
tion of cell death, although it demonstrates several other activ-
ities, like survival, axonal growth, and cell migration (2–5).
The precise mechanism as to how p75 transmits diverse sig-
nals in the normal or diseased nervous system remains elusive
(3). Signal transduction by p75 is thought to proceed via the
ligand-dependent recruitment and release of protein interac-
tors to and from the receptor (6). Although different oligomer
species have been recently described as the active receptor
(7–10), several lines of evidence support the dimeric nature of
p75 in neurotrophin signaling. NTs are homodimers in solution
(11) that dimerize the extracellular domain of p75 upon binding
as seen by in vivo cross-linking (12), by x-ray crystallography
(13, 14), and in solution (15). Engineered cysteine constructs
activate p75 in the absence of NGF by inducing constitutive
dimers (7), and the extracellular (16) and the intracellular
domain (17, 18) form stable dimers in solution. In addition, the
TM domain of p75 self-associates as measured by ToxCAT (8).
All these data are supported by FRET (8, 9) and by -galacto-
sidase protein-protein interaction assays (19), indicating that in
the absence of NTs a significant fraction of p75 exists as pre-
formed dimers on the plasma membrane.
Like several single span transmembrane receptors (20) p75
dimerization is not enough for its activation, and only specific
disulfide-linked dimers, mediated by Cys257 in the TM domain,
respond to NGF binding (8). Although the p75-C257A mutant
is still capable to form dimers and bind to NGF (8), it is unable
to transduce the signals triggered by NGF binding in some cell
signaling paradigms (8). In addition, p75-C257A is less prone to
-secretase processing (9) and has a reduced level of interaction
with the Nogo receptor (17). To provide insight into the con-
formation of p75 TM domain active disulfide dimers versus
p75-C257A inactive dimers, here we describe the high resolu-
tion NMR structure of the p75-WT and -C257A transmem-
brane domains.
Experimental Procedures
DNA Construct Design—p75 was expressed from the
pcDNA3 vector backbone (Invitrogen) using a full-length cod-
ing sequence flanked by an N-terminal hemagglutinin (HA)
epitope tag. Mutations were introduced by direct mutagenesis
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using Pfu Turbo DNA polymerase (Agilent), and the oligonu-
cleotide sequences are available upon request.
Constructs of p75 TM for Cell-free Expression—The gene
encoding the transmembrane and juxtamembrane residues
245–284 (MT245RGTTDNLIPVYCSILAAVVVGLVAYIAFK-
RWNSSKQNKQ284) of human p75 receptor (p75-TM-WT and
the C257A point mutant form of p75 TM (p75-TM-C257A))
was amplified by PCR from six chemically synthesized oligo-
nucleotides (Evrogen, Russia) partially overlapped along its
sequence. p75-TM-C257A was obtained by site-directed
mutagenesis by PCR. All constructs contained a mutation in the
palmitoylation site C279A to avoid the undesirable intermolec-
ular disulfide cross-linking. In our previously published work
with a longer construct of p75NTR (21), both the wild-type and
C279A variants were studied, and no difference in the NMR
spectra of the TM region were observed in both dodecylphos-
phocholine (DPC) micelles and dimyristoylphosphatidylcho-
line/dihexanoylphosphatidylcholine bicelles.
Cell-free Gene Expression—Bacterial S30 cell-free extract was
prepared from the Escherichia coli Rosetta (DE3) pLysS strain
from 10 liters of cell culture according to the previously
described protocol (22–24). The continuous exchange mode
with 12.5-kDa membrane was used in this study (23). Prepara-
tive scale reactions (2–3 ml of reaction mixture) were carried
out in 50-ml tubes. Optimal reaction conditions such as Mg2
and K concentrations, ratio of reaction mixture to feeding
mixture, and DNA concentration were established using home-
made reactors based on the mini-continuous exchange E. coli
cell-free reactor previously described (22, 23). The final stan-
dard feeding mixture:reaction mixture ratio was 8:1, and the
final cell-free reaction mixture contained 100 mM HEPES, 0.83
mM EDTA, KOH at pH 8.0, 0.1 mg/ml folinic acid, 20 mM
acetylphosphate, 1.2 mM ATP, and 0.8 mM each of G/C/UTP, 2
mM 1,4-dithiothreitol, 0.05% sodium azide, 2% PEG 8000, 20
mM magnesium acetate, 270 mM potassium acetate, 60 mM cre-
atine phosphate, 1 mM each of 20 amino acid or 0.25% of 20-
amino acid mixture (Cambridge Isotope Laboratories), one tab-
let/50 ml Complete protease inhibitor (Roche Applied Science),
0.5 mg/ml E. coli tRNA (Roche Applied Science), 0.25 mg/ml
creatine kinase from rabbit muscle (Roche Applied Science),
0.05 mg/ml T7 RNA polymerase prepared by a previously
described protocol (24), 0.1 unit/l Ribolock (Fermentas), 0.02
g/l plasmid DNA, and 30% S30 cell-free extract. All reagents
were provided by Sigma unless otherwise specified. Plasmid
DNA was purified using a Promega MaxiPrep kit. Reactions
were conducted overnight at 34 °C and 150 rpm in an Innova
44R shaker (New Brunswick).
Protein Purification—Cell-free reaction mixture was diluted
3 times with buffer A (50 mM Tris, pH 8.0, and 200 mM NaCl).
After 10 min of incubation, the mixture was centrifuged for 10
min at 18,000 g at room temperature. Precipitate was washed
consecutively with buffer A containing 30 g/ml RNase A (Fer-
mentas) and buffer B (50 mM Tris, pH 8.0, and 100 mM NaCl).
The target protein was solubilized with 200 l of buffer B con-
taining 1% lauryl sarcosine. After each step, the protein was
centrifuged for 10 min at 18,000  g at room temperature, and
supernatant aliquots were analyzed by 12.5% Tricine SDS-
PAGE (25).The clarified protein solution was applied onto a
10/300 Tricorn column prepacked with Superdex 200 (GE
Healthcare) and pre-equilibrated with buffer B containing 0.2%
lauryl sarcosine. Protein-containing fractions were combined
and precipitated by a TCA/acetone procedure (26).
Preparation of NMR Samples in a Membrane-mimetic
Medium—So-called “isotopic heterodimer” (1:1 mixture of
unlabeled and 15N/13C-labeled peptides) samples were pre-
pared for p75-TM-WT and p75-TM-C257A mutant to solve
the structure. The peptide powders of both samples were first
dissolved in 1:1 trifluoroethanol:H2O mixture with addition of
deuterated DPC (d38, 98%; Cambridge Isotope Laboratories)
and phosphate buffer, then kept for several minutes in an ultra-
sound bath, and lyophilized. After that dried samples were dis-
solved in 350 l of 9:1 H2O:D2O mixture. To attain uniformity
of the micelle size and distribution of the peptide throughout
micelles, samples were stored in an ultrasound bath for several
minutes until the solution was completely transparent. The
p75-TM-WT concentration of the isotopic heterodimer sam-
ple was 1.9 mM, lipid to protein ratio (LPR) 50:1, pH 5.9, 20 mM
phosphate buffer. The concentration of the mutant form p75-
TM-C257A was 1.5 mM, LPR 50:1, pH 5.9, 20 mM phosphate
buffer. Both samples were placed in Shigemi NMR tubes with
glass plunger. To elucidate an LPR ratio for p75-TM-WT-
C257A, an additional sample was prepared where only Gly, Phe,
Leu, Ala, and Tyr residues were 15N-labeled. These residues
were observed to be the most sensitive to oligomerization.
Selective residue labeling was implemented to avoid peak over-
lapping while processing the NMR spectra.
NMR Spectroscopy and Spatial Structure Calculation—NMR
spectra were acquired at 45 °C on 600- and 800-MHz AVANCE
III spectrometers (Bruker BioSpin, Germany) equipped with
the pulsed field gradient triple-resonance cryoprobes. 1H, 13C,
and 15N resonances of p75-TM-WT and p75-TM-C257A were
assigned with CARA software (27) using two- and three-dimen-
sional heteronuclear experiments (28): 1H/15N HSQC, 1H/15N
TROSY, 1H/13C HSQC, 1H/15N HNHA, 1H/13C/15N HNCA,
1H/13C/15N HN(CO)CA, 1H/13C/15N HNCO, three-dimen-
sional HCCH-TOCSY, and 13C- and 15N-edited NOESY-
HSQC (recorded on 600- and 800-MHz spectrometers, respec-
tively). Dimeric spatial structures were calculated with the
CYANA 3.0 program (29) based on torsion angle restraints esti-
mated from the chemical shift values with the standard proto-
col of the TALOS-N program (30) and intra- and intermono-
meric NOE distance restraints derived through the analysis of
three-dimensional 15N- and 13C-edited NOESY and 15N/13C-
F1-filtered/F3-edited NOESY spectra (28) acquired for isotopic
heterodimer samples. MOLMOL software was used to calcu-
late the contact areas between the dimer subunits and to visu-
alize the structures (31). Hydrophobic properties of the -heli-
ces in the p75-TM-WT and p75-TM-C257A dimers were
calculated using the molecular hydrophobicity potential
approach implemented in the program PREDDIMER (32).
ToxRED Assays—Original plasmids for ToxRED experi-
ments were kindly provided by Dr. W. Degrado (University of
California, San Francisco) and used as described (33). The
region encompassing p75 TM domain was cloned using PCR
with oligonucleotides with HindIII and XhoI to amplify the
region between Asp250 and Trp276 of p75. Plasmids encoding
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ToxR(GpA)MBP, ToxR(p75TM)MBP, and different p75 mu-
tants were transformed into E. coli MM39 cells and plated onto
Luria-Bertani (LB) plates (with 50 g/ml ampicillin). Colonies
were inoculated into LB medium (with 50 g/ml ampicillin).
Fresh LB cultures (with 50 g/ml ampicillin) were inoculated
from fresh plates, grown at 37 °C until approximately an A600 of
0.6 was reached, and harvested by centrifugation. Cells were
then lysed in lysis buffer (TNE, 50 mM Tris, pH 7.5, 150 mM
NaCl, 1 mM EDTA) in gentle conditions to avoid mCherry
denaturation. After transfer to 1.5-ml Eppendorf tubes, the
mixture was incubated at room temperature with gentle agita-
tion for 30 min. Samples were centrifuged for 10 min at
12,000  g to remove cell debris and clarify supernatants for
analysis. 150 l of clarified supernatant were transferred to
black optically clear 96-well plates. mCherry emission spectra
were collected using a plate reader (Tecan, Maennedorf, Swit-
zerland) with an excitation wavelength of 587 nm and emission
wavelengths of 610 – 650 nm. Afterward, aliquots were trans-
ferred from black to clear 96-well plates, and the absorbance
was measured from 450 to 750 nm. mCherry measurements
and construct expression measurements were performed in at
least 10 different colonies and were normalized for the relative
expression level of each construct using Western blotting with
MBP antibody. For Western blotting, samples were mixed with
equal volumes of 2 SDS-PAGE sample buffer, heated to 95 °C
for 10 min, separated on 10% (w/v) polyacrylamide minigels,
blotted onto nitrocellulose membranes, and probed with MBP
antibody. To analyze disulfide bond formation, bacteria colo-
nies were lysed using TNE plus 10 mM iodoacetamide and run
on non-reducing SDS-polyacrylamide gels.
In Vivo Cross-linking and Western Blotting Analysis—HeLa
cells were transfected with the indicated p75 constructs. 48 h
after transfection, cells were washed three time with cold PBS
and then cross-linked with bis(sulfosuccinimidyl)suberate
(Pierce) at 4 °C for 15 min. Afterward, cells were washed again
three times with PBS and incubated for 30 min with 0.15 M
glycine in 100 mM Tris-HCl, pH 7.5, to quench the cross-linker.
Cells were washed in PBS and lysed in cold lysis buffer (50 mM
Tris-HCl, pH7.5, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 0.1%
Triton X-100, 1 mM PMSF, 10 mM NaF, 1 mM Na2VO3, 10 mM
iodoacetamide, and protease inhibitor mixture) at 4 °C. Cellular
debris was removed by centrifugation at 13,000  g for 15 min,
and protein quantification was performed by Bradford assay.
Proteins were resolved by SDS-PAGE, and membranes were
incubated overnight at 4 °C with the following antibodies: rab-
bit polyclonal anti-human p75 (1:1000; reference number
G3231, Promega). Following incubation with the appropriate
secondary antibody, membranes were imaged using enhanced
chemiluminescence and autoradiography.
p75 Cleavage Experiments—p75 cleavage experiments were
carried out according to the protocol described previously by
Kanning et al. (34). Briefly, 48 h after transient transfection,
HeLa cells were incubated for 90 min with either 1 M protea-
some inhibitor epoxomicin (Sigma), 10 M Compound E (Mil-
lipore), or PBS buffer. Next, 200 nM phorbol 12-myristate
13-acetate (PMA; Sigma) was added for 40 min. The cells were
lysed and analyzed by SDS-PAGE and Western blotting using
p75 antibody as before.
Results
NMR Structure of p75 Transmembrane Domain Dimers—
p75-TM-WT, the 245–284 fragment of rat p75 (Fig. 1A, under-
lined), was produced in a cell-free system (23). We solubilized
the peptide in DPC micelles. Upon reconstitution, p75-
TM-WT monomers spontaneously and completely adopt a
dimeric conformation through a Cys257-Cys257 disulfide bond,
which cannot be easily disrupted by addition of -mercaptoeth-
anol or other reducing agents (Fig. 1B). The 15N HSQC spec-
trum of p75-TM-WT contains the expected number of cross-
peaks, and there are no significant minor forms observed,
indicating that approximately 100% of the peptide is in the
dimeric state (Fig. 1C). The use of 13C/15N-filtered NOESY
experiments allowed the direct detection of interhelical con-
tacts, which were used to calculate the spatial structure of the
dimer (Fig. 1D and Table 1). Secondary 13C chemical shifts for
Leu252 and Ile253 are about 0 ppm, suggesting a random coil
conformation. Thus, Pro254 is the first residue of the TM helix,
and Cys257 is located in the first turn of TM -helix close to the
water-lipid interface, which makes it accessible to the solvent.
The -helical region extends for 36 Å (residues 254 –276) and
consists of an uncharged region, Pro254–Phe273, and includes
positively charged Lys274 and Arg275 at the C terminus. Accord-
ing to the obtained structure, the dimerization of p75-TM-WT
is driven by the Cys257-Cys257 disulfide bond and is additionally
stabilized by intermolecular van der Waals interactions
between branched side chains of Leu260, Val264, Val265, and
Val268 and stacking interaction of Phe273 and Trp276 aromatic
rings (Fig. 1D).
p75-TM-WT Is a Weak Dimer under Reducing Conditions—
The formation of disulfide dimers is spontaneous and quanti-
tative. To study the conformation of p75-TM-WT in the
absence of a disulfide bond, we prepared different peptide sam-
ples. We were able to find more than 80% of the p75-TM-WT
free of disulfide bonds with solubilization of the peptide in the
presence of a nitrogen atmosphere and 20 mM DTT. Under
these conditions, p75-TM-WT is in a monomer-dimer equilib-
rium that depends on the LPR (Fig. 2A). To assess the propen-
sity of the protein for a non-covalent dimerization and to study
the conformation of such a dimer, a set of titration experiments
was performed (Fig. 2B) (35). This titration allowed us to mea-
sure a G0 (standard free energy of dimerization) equal to 0.9
kcal/mol (Fig. 2C). This suggests that p75-TM-WT dimer
under reducing conditions is rather weak if we compare with
other TM domain dimers like glycophorin A (G0  5 	 3
kcal/mol depending on membrane mimetic) (36 –38), VEGFR2
(G0  5 kcal/mol in DPC) (35), and ErbB4 (G0  1.4
kcal/mol in 1:4 dimyristoylphosphatidylcholine/dihexanoyl-
phosphatidylcholine bicelles) (35, 39), but it is in the order of
FGFR3 TM dimerization (G0  1 kcal/mol in 9:1 DPC:SDS
mixture) (40). We determined which residues in p75-TM-WT
experience chemical shift changes upon dimer formation. As
we observed in Fig. 2D, several residues throughout the whole
p75-TM-WT showed chemical shift changes, including Cys257,
suggesting that Cys257 may be a part of the non-covalent dimer
interface.
Structure of p75 Transmembrane Domain
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Our data indicate that, when a free Cys257 is present, the
disulfide bond is spontaneously formed, indicating that the
Cys-Cys interface is conformationally explored very quickly.
This suggests that Cys257 plays an important role in stabilizing
weak p75 transmembrane dimers by the formation of a disul-
fide bond.
NMR Structure of the p75-TM-C257A Dimer—p75-C257A is
inactive upon NGF binding, although it may form dimers as
cross-linking studies suggested (8). We characterized the struc-
ture of the p75-TM-C257A by NMR in DPC micelles. We
found that p75-C257A is in a monomer-dimer equilibrium (Fig.
3A) with a G0 equal to 1.8 kcal/mol (Fig. 3B), suggesting a
stronger dimerization than p75-TM-WT. To have a deeper
understanding of the structural basis of p75-C257A dimeriza-
tion, we carried out chemical shift assignment in NMR spectra
and structure calculation of p75-TM-C257A dimer. 15N HSQC
spectra of p75-TM-WT and p75-TM-C257A mutant are simi-
lar and well dispersed (Fig. 3C). The three-dimensional struc-
ture showed that the p75-TM-C257A TM helical regions
(Leu252–Trp276) associate in a left-handed parallel dimer via the
A262VXXG266XXA269 motif (Fig. 3D and Table 1) in contrast to
the p75-TM-WT dimerization that is right-handed. The motif
AXXXG is conserved in all p75 sequences (Fig. 1A) and was
previously suggested as a putative dimerization motif (7–9) due
to the similarity to GXXXG motifs described in TM domain
dimerization in several membrane proteins (41, 42). In addition
dimerization of p75-TM-C257A occurs via the relatively polar
part of the helical surface, and the C-terminal flank of the dimer
is stabilized by intermolecular stacking interactions between
aromatic rings of Phe273 residues. However, the observed mode
of p75-TM-C257A dimerization does not correspond to the
classical interaction via the GXXXG-like motifs. GXXXG-like
FIGURE 1. Solution structure of the p75-TM-WT disulfide-linked dimer in DPC micelles. A, schematic showing different p75 domains (CRD, cysteine-rich
domains; JTM, juxtamembrane domain; DD, death domain) and the protein sequence alignment of the TM domain (green box). The protein sequence used for
structural studies is underlined. Rn, Rattus norvegicus; Mm, Mus musculus; Hs, Homo sapiens; Gg, Gallus gallus; Xt, Xenopus tropicalis. B, SDS-PAGE analysis of p75
TM domain dimerization in 12% Tris-Tricine gel. SEC, size exclusion chromatography; -mercp, -mercaptoethanol. Bands are labeled as dimers or monomers
on the right. Molecular weights are indicated on the left. C, 1H/15N HSQC spectrum of p75-TM-WT solubilized in an aqueous suspension of DPC micelles at an
LPR of 50:1, 45 °C, and pH 5.9. 1H-15N backbone and side-chain resonance assignments are shown. D, schematic representation of the spatial structure of the
p75-TM-WT dimer from three different angles: front, 90° rotation. The Cys257-Cys257 disulfide bond is shown in yellow. The Protein Data Bank accession code for
p75-TM-WT is 2mic.
Structure of p75 Transmembrane Domain
JUNE 3, 2016 • VOLUME 291 • NUMBER 23 JOURNAL OF BIOLOGICAL CHEMISTRY 12349










motifs usually yield right-handed structures with the helix-
crossing angles in the range of 30 –50° in multihelical proteins
(43). The left-handed arrangement with the helix-crossing
angle equal to 66° found here may be a consequence of DPC
micelles used as a membrane-mimetic. The lateral pressure of
lipids in a bilayer and presence of the other TM helices would
affect the dimerization and tend to decrease the crossing angle.
Conversely, the GXXXG motif is not the paradigm for the helix-
helix interactions. The mode of the interaction is determined
by the properties of the surface of interacting helices. In our
case, one can clearly observe that C257A helices interact via a
relatively polar surface formed by the small-chain amino acids.
In fact, Ala262 is on the edge of the interface, and the real motif
would look like AVXXGXXAYXXF, and the key feature of the
interface is not only the polar interactions between Ala and Gly
residues but also the stacking of aromatic rings. 40° would be
obtained if the other surface, involving Ser258, Ala262, and
Gly266, is used.
The two obtained p75 TM dimer structures demonstrate
striking differences (summarized in Table 1 and Fig. 4). Both
structures have the same length of the TM helical region, 36 Å
(24 residues), but a significantly smaller crossing angle in p75-
TM-WT compared with p75-TM-C257A (36° versus 66°,
respectively) (Fig. 4A). The spatial distribution of the hydro-
phobic/hydrophilic properties of the p75-TM-WT dimer sub-
units, visualized by molecular hydrophobicity potential (44),
reveals that the packing interface extends by around 400 Å2 (per
subunit) and is located alongside the polar regions of the TM
helices (Table 1). Hydrophobicity plots in Fig. 4B show that the
two TM dimers use different contact residues that are located
on the opposing sides of the TM -helix to dimerize: the p75-
TM-WT dimer interface is C257XXXA261XXXV265, and the
p75-TM-C257A dimer interface is A262V263XXG266XXA269.
Some residues participate in both dimer interfaces, suggesting
that the two dimer interfaces are mutually exclusive.
The AXXXG Motif Is Not Mediating p75-TM-WT
Dimerization—We used ToxRED, a variation of the ToxCAT
system (33, 45), to monitor p75 TM domain dimerization in
bacterial membranes (Fig. 5). In ToxRED, dimerization of the
TM regions can be monitored by the activation of the reporter
gene mCherryFP (33). For that purpose, we introduced dif-
ferent mutations to the TM domain of p75, substituting the
residues to isoleucine, a more bulky residue (Fig. 5A). p75-TM-
A262I and p75-TM-G266I dimerize to a similar extent as p75-
TM-WT, suggesting that the contribution of the motif AXXXG
to p75 dimerization in this system is small (Fig. 5B). In contrast,
p75-C257I mutant forms dimers that are completely disrupted
by the double mutation p75-TM-C257I/G266I (Fig. 5B). This
confirms the NMR data, indicating that dimerization of p75-
TM-C257A is mediated by the AXXXG motif.
We then studied the dimerization of the full-length p75 in
the plasma membrane of transfected mammalian HeLa cells by
in vivo cross-linking using bis(sulfosuccinimidyl) suberate,
which does not cross the plasma membrane (Fig. 5C). Upon
transfection of the HeLa cells with the full-length p75, we
observed the presence of cross-linked dimers (Fig. 5C). The
amount of cross-linked dimers does not increase upon stimu-
lation with NGF (100 ng/ml), suggesting that p75 forms pre-
formed constitutive dimers in line with previous reports (8, 9,
19). Mutation of the Cys257 does not disrupt p75 full length
dimerization. Similarly, mutation of the AXXXGXXA motif
residues to isoleucines, mutant p75-AGA, has no effect on the
p75-WT dimerization (Fig. 5C), indicating that this motif does
not play an important role in p75 full length dimerization in
cells. However, when we mutated both Cys257 and the AGA
motif (mutant p75-C/AGA), we found a significantly smaller
amount of the bis(sulfosuccinimidyl) suberate-cross-linked
dimers (Fig. 5C), which is in line with the ToxRED and NMR
data.
These results support that the dimerization of p75-C257A is
mediated by the AXXXG motif in bacterial and mammalian
membranes. p75-WT dimerization, by contrast, is independent
of the AXXXG motif as we observed by NMR, ToxRED, and
cross-linking. Based on this, we suggest that the conformation
adopted by the C257A mutant may not reflect a native structure
of p75.
Role of AXXXG Motif in p75-regulated Intramembrane
Proteolysis—Although the GXXXG motifs are known to pro-
mote the homo- and heterodimerization of transmembrane
domains (41), recent evidence suggests that several GXXXG-
containing TM domains interact via alternative interfaces
involving hydrophobic, polar, or aromatic residues (46). This is
the case for p75-WT as the AXXXG motif does not mediate the
p75 homodimerization. However, because the AXXXG motif is
conserved in p75 sequences of different species, it is still possi-
ble that the motif is relevant in other functions of p75. p75
undergoes receptor intramembrane proteolysis (Fig. 6A), and
although the role of receptor intramembrane proteolysis in p75
signaling is still debated, it has been proposed that cleavage is
important for the biological functions of p75 (47–50). Recently
TABLE 1
Structural statistics for the 10 lowest target function NMR structures of
the p75-TM dimer in the DPC micelles
p75-TM-WT p75-TM-C257A
NMR distance and dihedral restraints
Total unambiguous NOE restraints 440 382
Intraresidue 78 128
Inter-residue 366 242
Sequential (i  j  1) 174 134
Medium range (1 
 i  j 
 4) 178 96
Long range (i  j  4) 14 12
Intermonomeric NOE 12 12
Hydrogen bond restraints (upper/lower) 84/84 102/102
Total torsion angle restraints 94 128
Backbone  42 52
Backbone  42 52
Side chain 1 10 14
Structure calculation statistics
CYANA target function (Å2) 1.80  0.35 2.40  0.19
Average pairwise r.m.s.d.,
-helical region 251–275 (Å)
Backbone atoms 0.37  0.09 0.38  0.1
All heavy atoms 0.92  0.17 0.92  0.21
Ramachandran analysisa
Residues in most favored regions (%) 75.0 88.9
Residues in additional allowed regions (%) 20.3 10.6
Residues in generously allowed regions (%) 4.4b 0.6
Residues in disallowed regions (%) 0.3b 0.0
Helix-helix packing
Contact surface area per dimer subunit (Å2) 400  50 320  40
Angle 	 between the helix axes (°) 36  5 66  5
Distance d between the helix axes, region
251–275 (Å)
8.8  0.5 7.2  0.5
a Ramachandran statistics were determined using CYANA (29).
b Residues from unfolded and flexible regions.
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Sykes et al. (9) found that mutation of the AXXXG motif to
LXXXL reduces p75 intramembrane proteolysis in HEK293 and
PC12 cells. This suggests that the AXXXG motif may play a role
in the recognition or the cleavage of the p75 by the -secretase
complex. Here, based on our structural studies, we investigated
whether the cleavage process differs for various p75 mutations
in the TM domain.
Shedding of the extracellular domain of p75 is a pre-requisite
for -secretase cleavage (60). Treatment with the phorbol ester
PMA, a metalloprotease activator that induces p75 shedding,
resulted in the generation of a p75 C-terminal fragment (p75-
CTF), which is the proper substrate for the -secretase com-
plex. p75 intracellular domain (p75-ICD) is generated by the
cleavage of p75-CTF, a process that is inhibited by the -secre-
tase inhibitor Compound E (Fig. 6B). Treatment with epoxomi-
cin, a proteasome inhibitor, helps to stabilize the p75-ICD,
which is otherwise rapidly degraded, and permits quantifica-
tion of -secretase activity via the p75-ICD to p75-CTF ratio, a
direct measure of the -secretase processing (Fig. 6, C and D).
HeLa cells were transfected with p75-WT and mutant con-
structs and treated with PMA for 40 min as described previ-
ously (34). The [p75-ICD]:[p75-CTF] ratio of p75-C257A was
significantly lower than that of p75-WT, suggesting attenuated
-secretase activity (Fig. 6D). A stronger effect is observed in
the p75-AGA mutant (Fig. 6D), which is almost resistant to the
action of the -secretase. The mutant p75-C/AGA with muta-
tions in the Cys257 and the AGA motif, also is less processed by
the -secretase complex. These results suggest that the small
residues that comprise the AXXXGXXA motif are important
for recognition and/or cleavage by -secretase rather than p75
homodimerization as we and others suggested previously (7, 9).
Discussion
We carried out our studies using solution NMR in detergent
micelles that do not always properly simulate the properties of
a real bilayer. Nanodiscs or bicelles are believed to better reflect
the lipid bilayer characteristics (47, 48). However, micelles
provide the smallest particles, which is of great importance
for solution NMR spectroscopy. Therefore spatial structures
obtained in micelles are of the best quality but may be non-
physiological. Conversely, alternative membrane mimetics are
also models of the lipid bilayer; lipid properties in nanodiscs
and bicelles do not correspond to those in liposomes (51), and
nanodiscs still cannot be used to solve the structures of trans-
membrane dimers due to their extremely large size. The bilayer
thickness and state of the lipids are almost never known for a
certain protein, so there always exists the possibility that incor-
rect choice of lipids in bicelles, nanodiscs, or liposomes can
affect the state of the transmembrane protein, whereas micelles
are much more flexible and can adopt their shape to the hydro-
phobic length of a transmembrane -helix. Recent studies that
were carried out for the same proteins (Bnip3 and glycophorin
A) in micelles, bicelles, and sometimes lipid bilayers did not
reveal any significant differences in the interfaces of helix-helix
interactions in transmembrane dimers (52–55). However, pro-
nounced differences were observed when the membrane-active
FIGURE 2. Dimerization of p75-TM-WT in reducing conditions. A, dimer-monomer population values were calculated from the integrals of cross-peak
projections in the 1H/15N TROSY spectra. B, percentage of the monomeric (blue) and dimeric (green) p75-TM-WT forms at different LPRs. C, calculation of the
apparent free energy of dimerization of p75-TM-WT. Gapp  RTln([M]2/[D]) as a function RTln(X) where X  ([Det]  Nm[M]  Nd[D])/Ne. [M], [D], and [Det]
represent monomer, dimer, and DPC concentration, respectively; Ne represents the number of DPC molecules per empty micelle; and Nm and Nd represent the
number of DPC molecules per micelle containing monomer and dimer, respectively. D, chemical shift changes observed in p75-TM-WT dimerization in 20 mM
DTT after titration at different LPRs. Error bars represent S.E.
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juxtamembrane region is present in the protein construct (56).
In our case, the juxtamembrane regions are absent, so we can
deem our data as reliable.
Although solution NMR is usually used to determine the
structure of TM domains, recently solid-state NMR approaches
proved to be efficient to determine the correct TM domain
topology, tilt, and TM-TM domain contacts in even more
native environment such as lipid bilayers (49 –52). We think
that solid-state NMR may be the method of choice to study the
orientation of the TM helix, but studies of helix-helix interac-
tions in dimers may be not feasible. To our knowledge, there is
only one successful attempt to resolve the structure of a helical
dimer in bilayers by solid-state NMR (55). This attempt
required a very expensive and time-consuming scheme of iso-
tope labeling and was accomplished with glycophorin A, which
is a remarkably stable dimer. In a case where both monomer
and dimer states were abundant and when there were motions
on the dimerization interface, such work would be impossible.
The structure of the p75 TM disulfide dimer that we describe
here sheds light on several aspects of p75 activation. Our exper-
iments showed that disulfide bonds are spontaneously formed
upon dimer formation. However, according to the TM domain
structure, Cys257 is in the first turn of the -helix, and therefore
it will reside close to the lipid-water interface in a real bilayer,
accessible to the aqueous environment necessary for the forma-
tion of the disulfide bond. Our studies on the isolated TM
FIGURE 3. Solution structure of the p75-TM-C257A dimer in DPC micelles. A, percentage of the monomeric (blue), dimeric (green), and oligomeric (red) forms
of p75-TM-C257A at different LPRs. Population values were calculated from the cross-peak intensities in the 1H/15N TROSY spectra. B, apparent free energy of
dimerization of p75-TM-C257A. Gapp  RTln([M]2/[D]) as a function RTln(X) where X  ([Det]  Nm[M]  Nd[D])/Ne. [M], [D], and [Det] represent monomer,
dimer, and DPC concentration, respectively; Ne represents the number of DPC molecules per empty micelle; and Nm and Nd represent the number of DPC
molecules per micelle containing monomer and dimer, respectively. C, 1H/15N HSQC spectrum of p75-TM-C257A solubilized in an aqueous suspension of DPC
micelles at an LPR of 50:1, 45 °C, and pH 5.9. 1H-15N backbone and side-chain resonance assignments are shown. D, schematic representation of the spatial
structure of the p75-TM-C257A dimer from two different angles; front, 90° rotation. TM helices are represented as ribbons, and side chains are represented as
sticks. The Protein Data Bank accession code for p75-TM-C257A is 2mjo. Error bars represent S.E.
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domain suggest that the dimerization of the transmembrane
domain per se is triggering the disulfide bond formation; once
two p75 TM domains dimerize, there is a high probability that
the disulfide bond is formed. In support of this, we observed the
presence of p75-TM-WT dimers in the absence of a disulfide
bond in an oxygen-free atmosphere and in the presence of
reducing agents, suggesting that the disulfide bond stabilizes an
otherwise weak TM dimer. However, in the context of the full-
length p75, this situation may be different, and the extracellular
or intracellular domains may modulate the rotation of the TM
domain in the plasma membrane to favor a specific interface.
Previously, an alternative in silico model of the p75 TM
dimer based on the glycophorin A (GpA) structure was pro-
posed (9). The model was built by threading the p75 TM
sequence on the structure of GpA dimer based on the assump-
tion that the AXXXG motif in p75-WT is mediating the
dimerization as does the GXXXG in the GpA dimer (57). How-
ever, the GXXXG-like motifs do not always participate in the
TM domain dimerization (46) as we showed here for p75-TM-
WT. In addition, p75 TM domain shares less than 10% of the
protein sequence with GpA, suggesting that drawing conclu-
sions from such a model may be risky. Our experimental data
suggest that the model is probably wrong because under our
experimental conditions p75-TM-WT forms the disulfide-
bonded dimers and not AXXXG dimers.
Our structural and functional analysis suggests that the
mutation C257A induces an essential rearrangement of the p75
TM dimer. NMR titration experiments suggest that Cys257 is
located on the dimer interface in both the disulfide-linked and
non-covalent dimers. Cysteine residues may participate in
hydrogen bond formation both intra- and intermolecularly
(58). In several protein structures, hydrogen bonds are found
between the sulfhydryl group of cysteine residue i and the car-
bonyl oxygen of residue i  4, and they play an important role
in stabilizing the -helix (58). In addition, reduced cysteine-
cysteine pairs form a dual hydrogen bond, contributing to a
higher stability of the dimer interface (58). Mutation of the
Cys257 will preclude the formation of these hydrogen bonds and
may distort the -helix structure, favoring a different dimer
interface. To our understanding, the different conformations of
p75-WT and p75-C257A provide a structural explanation to
the results showing that p75-C257A is inactive and its impact
on receptor intramembrane proteolysis. However, it raises the
concern that p75-C257A is actually not reflecting a native con-
formation of p75-WT, and care must be taken in extrapolating
some of the activities of p75-C257A to interrogate p75
signaling.
We confirmed previous observations that mutation of the
AXXXG motif contributes to a reduced cleavage catalyzed by
the -secretase complex (9). Interestingly, GXXXG motifs are
needed for the binding of the -secretase complex to the amy-
loid precursor protein (59). Although the recognition mecha-
nism by which the -secretase binds to its substrates is still
unknown, based on the fact that A262VV2VG266 motif of p75
is part of the target site for the -secretase cleavage (60), the
most plausible explanation is that mutations in this region
would induce a local conformational change in the -helix with
a negative impact on cleavage rather than mediating a protein-
protein interaction. Recently mutation of the Val264 impaired
the cleavage by -secretase, supporting this hypothesis (49).
In p75-C257A, the AXXXG motif is participating in the
homodimer formation and is less accessible to the -secretase
complex (Fig. 6E). This together with the different and probably
FIGURE 4. Different dimer conformations in p75-TM-WT and p75-TM-C257A. A, schematic illustration of the p75-TM-WT and p75-TM-C257A TM domains.
B, hydrophobicity map for the p75-TM-WT and p75-TM-C257A helix surface, calculated using PREDDIMER. Helix-packing interfaces are indicated with ovals.
Black and magenta ovals indicate the residues comprising the p75-TM-WT and p75-TM-C257A dimerization interfaces, respectively. The two panels to the right
show the percentage of intermonomer contact surface area.
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non-native conformation of the C257A dimer may contribute
to the reduced cleavage observed in this mutant.
Based on the functional data showing that the disulfide
dimers are required for the receptor activation, an important
question to answer is when and how they are formed. It is plau-
sible that most of the p75 in the membrane is in the form of a
homodimer or a heterodimer with another co-receptor. The
conformation imposed by the disulfide bond may release an
inhibitory state or lock a specific conformation necessary for
better positioning of the intracellular domain of p75 to bind the
effector proteins or the extracellular domain to bind the NTs
more efficiently. Actually a preformed dimer will increase the
affinity for its ligand quantitatively.
How a disulfide-linked dimer is able to transduce the signal-
ing after NGF binding is still an unsolved issue. A conforma-
tional model, as some of us proposed previously (8), is difficult
to imagine based on the restricted movement of a covalent
dimer and the intrinsic disorder of the juxtamembrane domain
of p75 (21). Alternatively, we propose that binding of NGF may
induce lateral interactions between several p75 disulfide-linked
dimers to form clusters. Clustering may be formed by extracel-
lular domain and/or ICD interactions and will promote an
increase in the affinity of the protein-protein interactions tak-
ing place in p75 signaling with proteins containing death
domains, caspase recruitment domains, and TNF receptor-as-
sociated factor domains. It is expected that up-regulation of p75
and the subsequent increase in p75 concentration at the mem-
brane will favor TM dimerization and the formation of more
disulfide-linked dimers. This may explain why elevated levels of
p75 are usually toxic by overexpression or after trauma (3, 61).
However, in homeostatic conditions, p75 TM dimerization
may be regulated by different mechanisms as different cell types
do not contain equivalent amounts of p75 disulfide dimers
despite showing similar p75 expression levels (8). Interaction of
p75 with other proteins that mask or block the accessibility of
the Cys257 could be one mechanism. As an example of this, we
recently described the formation of a covalent heterodimer
between the Cys257 of p75 and the homologous Cys58 of p45/
NRH2 that blocks the formation and signaling of the disulfide
homodimer of p75 (17). Other co-receptors, like TrkA, sortilin,
and Nogo receptor, that are reported to complex with p75 (62–
64) are candidates to modulate p75 dimerization as well. This
adds to the complexity of p75 TM dimer regulation.
Recently it has been proposed that p75 exists in the mem-
brane as a monomer and a trimer (10). The authors proposed
that p75 disulfide dimers are needed to bind another molecule
of p75 via the extracellular domain. Although the authors rely
exclusively on abnormally migrating bands on SDS-PAGE to
discern the stoichiometry, we cannot exclude that p75 disulfide
dimers may form oligomers with other copies of p75 in vivo.
However, to be observed in SDS-PAGE, these interactions need
to be SDS-resistant and take place outside of the TM domain as
we never detected a trimer species in our hands. That possibil-
ity is difficult to understand in the absence of more biochemical
data describing the nature of such strong protein-protein inter-
actions and taking into account that the “gel shifting” of mem-
brane proteins in SDS-PAGE is conformation-dependent (65).
Alternatively p75 disulfide dimers may bind to other compo-
nents of the plasma membrane and contribute to the abnormal
migration in SDS-PAGE. For instance, SDS-resistant aggre-
gates of p75 with components of the plasma membrane, like
gangliosides, have been described previously (66).
FIGURE 5. Dimerization of p75 by ToxRED and in mammalian cells. A,
sequences of the p75 TM mutant constructs used. The mutated residue is
shown in bold. B, left, percentage of dimerization, normalized to GpA-WT
(100%), of p75-TM-WT and p75 TM mutants (results represent the average
of at least 10 colonies analyzed in triplicate). GpA-wt* is a ToxRED negative
control with a mutation in the ToxR protein (33). C, in vivo cross-linking of
full-length p75 mutants in transfected HeLa cells. NGF (10 ng/ml) was used
in the lanes indicated. Cells were lysed in the presence of iodoacetamide,
subjected to reducing SDS-PAGE, and then immunoblotted and probed
with a specific p75 antibody against p75-ICD. Error bars represent S.E. BS3,
bis(sulfosuccinimidyl)suberate. * refers to non-specific protein band.
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To conclude, during the preparation of this manuscript, the
structure of the trimer of Fas transmembrane domain was
reported (67). Although p75 was the founding member of the
TNF receptor superfamily (68, 69), in several respects p75 is an
atypical member. Most TNF receptor proteins signal in trim-
eric form and are activated by trimeric TNF-like ligands,
whereas p75 forms dimers and is activated by dimeric NTs that
are structurally unrelated to the TNF-like ligands (69). Our
structural studies presented here add another exclusive charac-
teristic of p75 among the TNF receptor superfamily members
and confirm a considerable amount of data supporting the
dimeric nature of p75.
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